Clinical variation in the organization of clinical pathways in esophagogastric cancer, a mixed method multiple case study

Autor: Luijten, J., Vissers, Pauline A.J., Brom, L., Bièvre, M. de, Buijsen, J., Rozema, T., Mohammad, N.H., Duijvendijk, P. van, Kouwenhoven, E.A., Eshuis, W.J., Rosman, C., Siersema, P.D., Laarhoven, H.W.M. van, Verhoeven, R.H.A., Nieuwenhuijzen, G.A., Westerman, M.J.

Publikováno v: BMC Health Services Research, 22(1):527. BioMed Central
BMC health services research, 22(1):527. BioMed Central
BMC Health Services Research, 22
BMC Health Services Research, 22(1):527. BioMed Central Ltd
Luijten, J C H B M, Vissers, P A J, Brom, L, de Bièvre, M, Buijsen, J, Rozema, T, Mohammad, N H, van Duijvendijk, P, Kouwenhoven, E A, Eshuis, W J, Rosman, C, Siersema, P D, van Laarhoven, H W M, Verhoeven, R H A, Nieuwenhuijzen, G A P & Westerman, M J 2022, ' Clinical variation in the organization of clinical pathways in esophagogastric cancer, a mixed method multiple case study ', BMC Health Services Research, vol. 22, no. 1, 527 . https://doi.org/10.1186/s12913-022-07845-2
BMC Health Services Research, 22, 1

Background Among esophagogastric cancer patients, the probability of having undergone treatment with curative intent has been shown to vary, depending on the hospital of diagnosis. However, little is known about the factors that contribute to this va

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::117dd973d1ce278dc51ed328563ececf
https://research.vumc.nl/en/publications/93dc58ec-d63f-49d3-9298-4b8e5a00878f

Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Autor: Anders Sundin, Johanna Arola, Peter Stålberg, Camilla Schalin-Jäntti, Seppo W. Langer, Espen Thiis-Evensen, Gitte Dam, Andreas Kjaer, U. Knigge, Henning Grønbæk, Halfdan Sorbye, Eva Tiensuu Janson, Birgitte Federspiel, Staffan Welin

Publikováno v: Janson, E T, Knigge, U, Dam, G, Federspiel, B, Grønbaek, H, Stålberg, P, Langer, S W, Kjaer, A, Arola, J, Schalin-Jäntti, C, Sundin, A, Welin, S, Thiis-Evensen, E & Sorbye, H 2021, ' Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms ', Acta Oncologica, vol. 60, no. 7, pp. 931-941 . https://doi.org/10.1080/0284186X.2021.1921262
Acta Oncologica

Background The diagnostic work-up and treatment of patients with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) has undergone major advances and new methods are introduced. Furthermore, an update of the WHO classification has resulted in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9988b8bdc5f28489826e236f748e49ab
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-454175

Neoplastic and pre-neoplastic lesions of the oesophagus and gastro-oesophageal junction

Autor: Irene Gullo, Alessandro Vanoli, Luca Mastracci, Paola Parente, Michele Paudice, Jacopo Ferro, Francesco Limarzi, Matteo Fassan, Luca Saragoni, Federica Grillo

Publikováno v: Pathologica

Summary Oesophageal and gastro-oesophageal junction (GOJ) neoplasms, and their predisposing conditions, may be encountered by the practicing pathologist both as biopsy samples and as surgical specimens in daily practice. Changes in incidence of oesop

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a7ddfcd60cfe9841b46bff921c01a02
http://hdl.handle.net/11567/1039643

Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing

Autor: Carla Oliveira, Roland P. Kuiper, Hildegunn Høberg-Vetti, James R. Lupski, Encarna B. Gomez Garcia, Margreet G. E. M. Ausems, Christian Gilissen, Liesbeth Spruijt, Elke Holinski-Feder, C. Marleen Kets, Urszula Teodorczyk, Jelle J. Goeman, Rachel S. van der Post, Ad Geurts van Kessel, Anja Wagner, Alexander Hoischen, Anna Jakubowska, Wendy A. G. van Zelst-Stams, Rolf H. Sijmons, Cora M. Aalfs, Nicoline Hoogerbrugge, Maartje van de Vorst, Marjolijn J. L. Ligtenberg, Maurizio Genuardi, Shalini N. Jhangiani, Jan Lubinski, Lisenka E.L.M. Vissers, Frederik J. Hes, Inga Bjørnevoll, J. Han van Krieken, Hugo Pinheiro, Hans K. Schackert, Joep de Ligt, Ingrid P. Vogelaar, Guglielmina Nadia Ranzani, Donna M. Muzny, Liselotte P. van Hest, Richard A. Gibbs, Lizet E. van der Kolk, Valeria Molinaro

Publikováno v: European Journal of Human Genetics, 25, 11, pp. 1246-1252
European Journal of Human Genetics, 25(11), 1246. Nature Publishing Group
European Journal of Human Genetics, 25(11), 1246-1252. Nature Publishing Group
European journal of human genetics, 25(11), 1246-1252. Nature Publishing Group
European Journal of Human Genetics, 25, 1246-1252
European Journal of Human Genetics
Vogelaar, I P, Van Der Post, R S, Van Krieken, J H J M, Spruijt, L, Van Zelst-Stams, W A G, Kets, C M, Lubinski, J, Jakubowska, A, Teodorczyk, U, Aalfs, C M, Van Hest, L P, Pinheiro, H, Oliveira, C, Jhangiani, S N, Muzny, D M, Gibbs, R A, Lupski, J R, De Ligt, J, Vissers, L E L M, Hoischen, A, Gilissen, C, Van De Vorst, M, Goeman, J J, Schackert, H K, Ranzani, G N, Molinaro, V, García, E B G, Hes, F J, Holinski-Feder, E, Genuardi, M, Ausems, M G E M, Sijmons, R H, Wagner, A, Van Der Kolk, L E, Bjørnevoll, I, Høberg-Vetti, H, Van Kessel, A G, Kuiper, R P, Ligtenberg, M J L & Hoogerbrugge, N 2017, ' Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing ', European Journal of Human Genetics, vol. 25, no. 11, pp. 1246-1252 . https://doi.org/10.1038/ejhg.2017.138
European Journal of Human Genetics, 25(11), 1246-1252

Contains fulltext : 182216.pdf (Publisher’s version ) (Open Access) Recognition of individuals with a genetic predisposition to gastric cancer (GC) enables preventive measures. However, the underlying cause of genetic susceptibility to gastric canc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8924302c8b22121fd84e066e6595ac39
https://doi.org/10.1038/ejhg.2017.138

What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?

Autor: Daniel Humberto Pozza, A Craig Lockhart, Ramon Andrade de Mello, Matthew Salzberg, Sofia Palacio, Pedro Castelo-Branco, Louis Vermeulen, Luis Castelo-Branco

Publikováno v: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 38

Esophageal cancer and gastric cancer are aggressive diseases for which treatment approaches are facing a new era. Some molecular pathways, such as VEGF, EGFR, fibroblast growth factor receptor, PIK3CA, and PARP-1, have been studied, and novel targete

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::563866196bd4101a866171a5dd604ba2
https://pubmed.ncbi.nlm.nih.gov/30231398